StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): a randomised, double-masked, sham-controlled, clinical trial comparing low-voltage X-ray irradiation and as needed bevacizumab, with as needed bevacizumab monotherapy

Project: Research

Project Details

Effective start/end date1/12/201431/10/2022

Collaborative partners

  • King's College London (lead)
  • KCH King's College Hospital NHS Foundation Trust
  • Oraya Therapeutics, Inc.
  • Queen's University Belfast
  • University of Bristol
  • University of Oxford


  • NIHR National Institute For Health & Care Research: £2,240,168.00